Hematology / Oncology Fellowship

Batra Sandeep, MBBS

Batra Sandeep, MBBS Batra Sandeep, MBBS

Clinical Assistant Professor of Pediatrics
Areas of Interest: Pediatric Leukemias and solid tumor biology, clinical trials involving new agents.
James Croop, MD, PhD

James Croop, MD, PhD James Croop, MD, PhD

Professor of Pediatrics
Areas of Interest: Developing new and novel agents for treating children with cancer.
David Delgado, MD

David Delgado, MD David Delgado, MD

Assistant Professor of Pediatrics
Areas of Interest: I am interested in studying novel agents to prevent graft-vs-host disease (GVHD), a common complication of donor stem cell transplant.
Robert Fallon, MD, PhD

Robert Fallon, MD, PhD Robert Fallon, MD, PhD

Director, Section of Pediatric Hematology/Oncology
Areas of Interest: Pediatric Oncology, Hodgkins Disease and Lymphoma; Sickle Cell Disease; Clinical trials on new cancer drugs.
W. Scott Goebel, M.D, Ph.D.

W. Scott Goebel, M.D, Ph.D. W. Scott Goebel, M.D, Ph.D.

Assistant Professor of Pediatrics
Areas of Interest: My clinical/translational research interests include cellular therapies to enhance hematopoietic stem cell transplantation and reduce regimen-related toxicities, and gene therapy for hematopoietic diseases.
Kerry M. Hege, MD

Kerry M. Hege, MD Kerry M. Hege, MD

Clinical Assistant Professor of Pediatrics
Areas of Interest: Coagulation Disorders, Hemophilia
Mark R. Kelley, Ph.D.

Mark R. Kelley, Ph.D. Mark R. Kelley, Ph.D.

Professor, Departments of Pediatrics, Biochemistry & Molecular Biology and Pharmacology & Toxicology
Associate Director, Herman B Wells Center for Pediatric Research
Areas of Interest: Dr. Kelley’s laboratory studies DNA repair genes involved in repairing base damage that occurs from oxidative and alkylation events in normal and tumor cells and following cancer treatments. Ongoing projects include: 1) Studying the multifunctional Ape1/Ref-1 protein structure/function in order to determine its redox and repair functions in normal and cancer cells, 2) Molecular targeted therapeutic approaches at members of the DNA base excision repair (BER) pathway, 3) Altering Ape1’s redox function and role in angiogenesis as a therapeutic approach for cancer and other indications, 4) Role of DNA repair genes in cognitive dysfunction (“chemobrain”) and peripheral neuropathy.
Holly Knoderer, MD, MS

Holly Knoderer, MD, MS Holly Knoderer, MD, MS

Clinical Assistant Professor of Pediatrics
Areas of Interest: Dr Knoderer specializes in the clinical care of children and adolescents with all types of cancer and blood disorders.
Melissa Markel, MD, MS

Melissa Markel, MD, MS Melissa Markel, MD, MS

Assistant Professor of Clinical Pediatrics
Areas of Interest: Brain tumors, solid tumors, plexiform neurofibromas.
Lindsey D. Mayo, Ph. D

Lindsey D. Mayo, Ph. D Lindsey D. Mayo, Ph. D

Associate Professor of Pediatrics
Areas of Interest: Understanding how tumor suppressor and oncogenes become altered to promote tumor metastasize and become resistant to conventional therapy.
Emily L Mueller, MD, MSc, FAAP

Emily L Mueller, MD, MSc, FAAP Emily L Mueller, MD, MSc, FAAP

Assistant Professor of Pediatrics
Areas of Interest: Pediatric lymphoma, Pediatric solid tumors, Health Policy and Health Care Utilization, Bioinformatics.

Grzegorz Nalepa, M.D., Ph. D Grzegorz Nalepa, M.D., Ph. D

Assistant Professor of Pediatrics
Areas of Interest: Fanconi anemia and other bone marrow failure syndromes, cancer genetics and cancer predisposition syndromes, genomic instability, mitosis, aneuploidy, chromosome segregation, MDS, acute leukemias, personalized therapeutics.
Sophie Paczesny, MD, PhD

Sophie Paczesny, MD, PhD Sophie Paczesny, MD, PhD

Associate Professor
Areas of Interest: Pediatric hematology/oncology, particularly in HSCT, with my focus on translational research science and with the goal of converting bench discoveries to the bedside.
Karen E. Pollok, PhD

Karen E. Pollok, PhD Karen E. Pollok, PhD

Associate Professor of Pediatrics
Areas of Interest: Building upon standard-of-care therapy for glioblastoma and neuroblastoma by modulation of dysregulated signaling networks.
Kamnesh R. Pradhan, MBBS, MS

Kamnesh R. Pradhan, MBBS, MS Kamnesh R. Pradhan, MBBS, MS

Clinical Assistant Professor of Pediatrics
Areas of Interest: Biomarkers of pathological angiogenesis in cancer, cancer survivors, and sickle cell anemia, health promotion to enhance vascular health among cancer survivors.
Susanne Ragg MD, PhD

Susanne Ragg MD, PhD Susanne Ragg MD, PhD

Associate Professor of Pediatrics
Areas of Interest: Clinical interest: oncology and chelation therapy, clinical trials. Research interest: Proteomics in cancer (Wilms tumor, osteosarcoma, neuroblastoma), sickle cell disease, childhood obesity and inflammatory bowel syndrome as well as glaucoma; Biobank collection and storage of serum, plasma, urine, aqueous and vitreous fluid.
Jamie Renbarger, M.D., M.S.

Jamie Renbarger, M.D., M.S. Jamie Renbarger, M.D., M.S.

Associate Professor of Pediatrics (Hematology/Oncology)
Adjunct Associate Professor of Medicine (Clinical Pharmacology) and Obstetrics and Gynecology
Associate Director, Indiana Institute for Personalized Medicine
Nora Letzter Scholar in Pediatric Oncology
Academic Section Chief, Pediatric Hematology/Oncology
Areas of Interest: My primary research interest as a pediatric oncologist/stem cell transplant physician is in personalized medicine and pharmacogenomics in the treatment of childhood cancers.
Kent A. Robertson, M.D., Ph.D., FAAP

Kent A. Robertson, M.D., Ph.D., FAAP Kent A. Robertson, M.D., Ph.D., FAAP

Professor of Pediatrics
Areas of Interest: Stem Cell Transplant, Neurofibromatosis
Chie-Schin Shih, MD, MSc

Chie-Schin Shih, MD, MSc Chie-Schin Shih, MD, MSc

Associate Professor of Pediatrics
Areas of Interest: Developmental therapeutics in Brain and Spinal cord tumors, novel diagnostic imaging techniques for brain tumors, developmental therapeutics in neurofibromatosis, palliative care.
Jodi Skiles, MD, MS

Jodi Skiles, MD, MS Jodi Skiles, MD, MS

Assistant Professor of Pediatrics
Areas of Interest: Biomarkers of Vincristine Toxicity in Kenyan Children with Cancer, High Risk Leukemia and genetic predictors of response to therapy, Adolescents and Young Adults with cancer.
Terry Vik, M.D.

Terry Vik, M.D. Terry Vik, M.D.

Professor of Pediatrics
Director, Childhood Cancer Survivor Program
Director, Fellowship Program in Pediatric Hematology-Oncology
Director, Clinical Pediatric Hematology-Oncology at Riley Hospital 
Areas of Interest: Global Health: Childhood Cancer Treatment Program in Kenya, Translational Research: Fostering new project development through the CTSI, Cancer Survivorship: Facilitating research with childhood cancer survivors.
Jingwu Xie, PhD

Jingwu Xie, PhD Jingwu Xie, PhD

Herman B Wells Center for Pediatric Research
Areas of Interest: Signal transduction of the hedgehog pathway and its role in the development of cancer (basal cell carcinoma, pediatric rhabdomyosarcomas and pancreatic cancer).
Allison Yancey, M.D, M.S.

Allison Yancey, M.D, M.S. Allison Yancey, M.D, M.S.

Clinical Assistant Professor of Pediatrics
Areas of Interest: Clinical Oncology. Patient safety and quality of care initiatives (Co-director of the Quality Improvement Council for the Pediatric Hematology/Oncology division.)